Fractional CTO for HealthTech Companies

The defining tension in HealthTech is between velocity and safety, and it shows up everywhere. Regulatory compliance is the baseline: in Canada that means PHIPA and PIPEDA, and any US expansion adds HIPAA — each with specific requirements for consent, breach notification, and safeguards that have to be designed in, not bolted on.

PHI data governance is genuinely hard. Knowing where protected health information lives, who can access it, how it is encrypted, how long it is retained, and how it is de-identified for analytics requires deliberate architecture. Security posture for clinical data has to withstand the scrutiny of hospital procurement and infosec teams, whose questionnaires can stall a promising deal for months.

Integration is its own discipline: connecting to electronic health records through HL7 and FHIR is where interoperability lives, and it is unforgiving of shortcuts. Layer on the need for continuous audit-readiness — being able to prove, at any moment, who touched what — and the pressure to keep shipping, and it is easy to see why HealthTech founders reach a technical ceiling.

We make compliance an architectural property rather than a scramble before each deal. First we map every place PHI enters, moves through, and rests in the system, then design governance around it — encryption at rest and in transit, least-privilege access, comprehensive audit logging, retention and de-identification policies aligned to PHIPA, PIPEDA, and HIPAA.

We build the security posture health systems expect, and we prepare the documentation and controls that answer hospital infosec questionnaires quickly, so procurement stops being a black hole. On integration, we implement HL7 and FHIR interfaces properly — mapping, validation, and error handling — so data exchange with EHRs is reliable rather than brittle.

Critically, we resolve the velocity-versus-safety tension with process rather than heroics: change controls, environments that separate real PHI from development, and automated checks that let the team ship steadily without risking a breach. The goal is a system that is continuously audit-ready, not one that panics before every review.

We also prepare the firm for the conversations that decide deals — assembling the security documentation, data-flow diagrams, and control evidence that hospital and clinic infosec teams request, and coaching the founders on how to answer them credibly. When those materials already exist and map cleanly to PHIPA, PIPEDA, and HIPAA, a review that once threatened to stall for months becomes a structured exchange that moves at the pace of the sale rather than the pace of the questionnaire.

The result is a HealthTech platform that clinical buyers can trust and regulators cannot easily fault. Hospital and clinic security reviews move faster because the controls, documentation, and audit trails are already in place, shortening sales cycles that used to stall for months. PHI is governed deliberately — encrypted, access-controlled, and logged — so a breach becomes far less likely and far more defensible if it ever occurs.

EHR integrations through HL7 and FHIR work reliably, making the product genuinely interoperable rather than a demo that breaks in production. And the team ships at a sustainable pace, because safety is built into the workflow instead of fought for after the fact. You get the confidence of senior technical leadership that has carried clinical software through real regulatory scrutiny.

The compounding benefit is credibility. In HealthTech, the ability to demonstrate mature data governance and a defensible security posture is itself a competitive advantage — it opens doors to health-system partnerships, reassures investors during due diligence, and shortens every future procurement conversation. By making that maturity a permanent property of the platform rather than a one-time push, we help the company earn trust it can keep drawing on as it grows into new clinical settings and, eventually, new jurisdictions.